Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune(®) vaccine

In order to assess the immunotherapeutic potential on canine visceral leishmaniasis of the Leishmune(®) vaccine, formulated with an increased adjuvant concentration (1 mg of saponin rather than 0.5 mg), 24 mongrel dogs were infected with Leishmania (L.) chagasi. The enriched-Leishmune(®) vaccine was...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, F.N., Borja-Cabrera, G.P., Miyashiro, L.M., Grechi, J., Reis, A.B., Moreira, M.A.B., Martins Filho, O.A., Luvizotto, M.C.R., Menz, I., Pessôa, L.M., Gonçalves, P.R., Palatnik, M., Palatnik-de-Sousa, C.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115527/
https://www.ncbi.nlm.nih.gov/pubmed/17630055
http://dx.doi.org/10.1016/j.vaccine.2007.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115527/
https://www.ncbi.nlm.nih.gov/pubmed/17630055
http://dx.doi.org/10.1016/j.vaccine.2007.06.005

Ejemplares similares